中文 | English
Return
Total: 1912 , 1/192
Show Home Prev Next End page: GO
Author:(Yan-hong XU)

1.Disease burden of chronic kidney disease attributable to high BMI in China and trend prediction in 1992-2021

Hong LIU ; Guimao YANG ; Yan SUI ; Xia ZHANG ; Xuebing CHENG ; Yaxing WU ; Xu GUO ; Yanfeng REN

Journal of Public Health and Preventive Medicine 2025;36(1):27-31

2.Three new gallic acid sugaresters from Elaeagnus oxycarpa Schlechtend leaves and their antioxidant and tyrosinase inhibitory activities

Feng-zhen CUI ; Jian-hong FU ; Guo-yan XU ; AYEKABAYR·EKBAYR ; Chang-da MA

Acta Pharmaceutica Sinica 2025;60(2):434-441

3.A Case Report of Pachydermoperiostosis by Multidisciplinary Diagnosis and Treatment

Jie ZHANG ; Yan ZHANG ; Li HUO ; Ke LYU ; Tao WANG ; Ze'nan XIA ; Xiao LONG ; Kexin XU ; Nan WU ; Bo YANG ; Weibo XIA ; Rongrong HU ; Limeng CHEN ; Ji LI ; Xia HONG ; Yan ZHANG ; Yagang ZUO

JOURNAL OF RARE DISEASES 2025;4(1):75-82

4.Research on cardiometabolic risk factors of workers in new forms of employment

Siyuan WANG ; Xiaoshun WANG ; Rui GUAN ; Hong YU ; Xin SONG ; Binshuo HU ; Zhihui WANG ; Xiaowen DING ; Dongsheng NIU ; Tenglong YAN ; Huadong XU

China Occupational Medicine 2025;52(2):150-154

5.Multidimensional optimization strategies and practical effects of prescription pre-review system

Guangming GAO ; Tianjiao LIU ; Na XU ; Jing LIANG ; Xiangju SUN ; Zhanguo ZHU ; Hong YAN

China Pharmacy 2025;36(14):1797-1801

6.Investigation of an outbreak of group A human G9P [8] rotavirus infectious diarrhea among adults in Chongqing

Yang WANG ; Yuan KONG ; Ning CHEN ; Lundi YANG ; Jiang LONG ; Qin LI ; Xiaoyang XU ; Wei ZHENG ; Hong WEI ; Jie LU ; Quanjie XIAO ; Yingying BA ; Wenxi WU ; Qian XU ; Ju YAN

Shanghai Journal of Preventive Medicine 2025;37(8):663-668

7.Diagnostic value of CD4+T cells combined with interleukin-8 in human immunodeficiency virus-associated cytomegalovirus retinitis

Qi AN ; Ye YING ; Yan XU ; Hao HONG

International Eye Science 2025;25(11):1854-1858

8. MW-9, a chalcones derivative bearing heterocyclic moieties, ameliorates ulcerative colitis via regulating MAPK signaling pathway

Zhao WU ; Nan-Ting ZOU ; Chun-Fei ZHANG ; Hao-Hong ZHANG ; Qing-Yan MO ; Ze-Wei MAO ; Chun-Ping WAN ; Ming-Qian JU ; Chun-Ping WAN ; Xing-Cai XU

Chinese Pharmacological Bulletin 2024;40(3):514-520

9.Systematic characterization and identification of the chemical constituents of the Schisandra chinensis decoction based on a hybrid scanning technique of UHPLC/IM-QTOF-MS

Li-li HONG ; Hong-da WANG ; Xiao-yan XU ; Wan-di HU ; Jing-yuan LIU ; Xiao-ying WANG ; Xiu-mei GAO ; Wen-zhi YANG

Acta Pharmaceutica Sinica 2024;59(3):678-692

10.The role of glucose metabolism reprogramming and its targeted therapeutic agents in inflammation-related diseases

Yi WEI ; Xiao-man JIANG ; Shi-lin XIA ; Jing XU ; Ya LI ; Ran DENG ; Yan WANG ; Hong WU

Acta Pharmaceutica Sinica 2024;59(3):511-519

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1912 , 1/192 Show Home Prev Next End page: GO